Hostname: page-component-848d4c4894-8kt4b Total loading time: 0 Render date: 2024-06-26T00:56:41.331Z Has data issue: false hasContentIssue false
  • English
  • Français

Fluctuation of Plasma Cortisol Levels in Multiple Sclerosis

Published online by Cambridge University Press:  18 September 2015

F. M. Butterworth ,
G. E. Ristow  and
E. Collarini
F. M. Butterworth*
Affiliation:
Department of Biological Sciences, Oakland University, Rochester, Michigan and the Department of Neurology, Wayne State University
G. E. Ristow
Affiliation:
Department of Biological Sciences, Oakland University, Rochester, Michigan and the Department of Neurology, Wayne State University
E. Collarini
Affiliation:
Department of Biological Sciences, Oakland University, Rochester, Michigan and the Department of Neurology, Wayne State University
*
Dept. of Biological Sciences, Rochester Michigan 48063 U.S.A.
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Using radioimmunoassay, the levels of plasma cortisol of 23 patients with multiple sclerosis and 10 control subjects were determined at three or more times over a one-year period. The status of the disease was ascertained by neurological examination at the same time. Twelve of the patients were considered stable because they showed no changes in their disease status during the year. The remaining 11 patients were designated active since each had one or more relapses. The levels of cortisol of the control and stable groups remained relatively constant during the one-year period, but the levels of the active group fluctuated significantly more than either of the other two groups. Furthermore the active patients who had more than one episode had the greatest fluctuation in their cortisol levels. The fluctuations could indicate some endocrinologie al aberration in patients with active multiple sclerosis or may be secondary to the influence of the disease.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 6 , Issue 1 , February 1979 , pp. 59 - 63
Copyright
Copyright © Canadian Neurological Sciences Federation 1979

References

Abraham, G. E., Buster, J. E., and Teller, R. C. (1972): Radioimmunoassay of plasma cortisol. Annalyt. Letters 5, 757–765.Google Scholar
Cendrowski, W. S. (1975): Pilot-study on large dose alternate-day therapy in multiple sclerosis. Schw. Arch. f. Neurol. Neuroch. u. Psych. 117, 197–203.Google ScholarPubMed
Czeisler, C. A., Ede, M. C. M., Regestein, Q. R., Kisch, E. S., Fang, V. S., and Ehrlich, E. N. (1976): Episodic 24-hour cortisol secretory patterns in patients awaiting cardiac surgery. J. clin. Endocrinol. Metab. 42, 273–283.CrossRefGoogle ScholarPubMed
Garcia-Reyes, J. A., Jenkins, D.Forsham, P. H., and Thorn, G. W. (1952): Adrenocortical function in multiple sclerosis. AMA Arch. Neurol. Psychiat. 62, 776–782.CrossRefGoogle Scholar
Genazzini, A. R., Lemarchand-Beraud, T., Aubert, M. L., and Felber, J. P. (1975): Pattern of plasma ACTH, hGH, and cortisol during menstrual cycle. J. clin. Endocrinol. Metab. 41, 431–437.CrossRefGoogle Scholar
Goust, J. M., Chenais, F., Carnes, J. E., Hames, C. G., Fundenberg, H. H., and Hogan, E. L., (1978): Abnormal T cell subpopulations and circulating immune complexes in the Guillain-Barre syndrome and multiple sclerosis. Neurology 28, 421–425.CrossRefGoogle ScholarPubMed
Hommes, O. R., Prick, J. J. G., and Lammers, K. J. B. (1975): Treatment of the chronic progressive form of multiple sclerosis with a combination of cyclophos-phamide and prednisone. Clin. Neurol. Neurosurg. 78, 59–72.CrossRefGoogle Scholar
Knight, S. C., Lance, E. M., Abbosh, J., Monro, A., and O'Brien, J. (1975): Intensive immunosuppression in patients with disseminated sclerosis. III. Lymphocyte response in vitro. Clin. exp. Immunol. 21, 23–31.Google ScholarPubMed
Myers, L. W., and Ellison, G. W. (1975): Longitudinal study of the immune response to normal human white matter in multiple sclerosis. Neurology 25, 351.Google Scholar
Millac, P., Cook, D. C., and Chase, K. (1969): Endocrine function in multiple sclerosis, J. Neurol. Neurosurg. Psychiat. 32, 414–418.CrossRefGoogle ScholarPubMed
Millar, J. H. D., Vas, C. J., Noronka, M. J., Liversedge, L. A., and Rawson, M. D. (1967): Long-term treatment of multiple sclerosis with corticotrophin. Lancet 1, 429–431.Google Scholar
Rose, A. S.Ellison, G. W., Myers, L. W. and Tourtellotte, W. W. (1976): Criteria for the clinical diagnosis of multiple sclerosis. Neurology 26, 20–22.CrossRefGoogle ScholarPubMed
Sachar, E. J. (1975): Twenty-four-hour cortisol secretory patterns in depressed and manic patients. Prog. Brain Res. 42, 81–91.CrossRefGoogle ScholarPubMed
Schumacher, G. A., Beebe, G., Kibler, R. F., Kurland, L. T., Kurtzke, J. F., Mcdowell, F., Nagler, B., Sibley, W. A., Tourtellotte, W. W., and Willmon, T. L. (1965): Problems of experimental trials of therapy in multiple sclerosis: Report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. N.Y. Acad. Sci. Ann. 122, 552–568.CrossRefGoogle Scholar
Teasdale, G. M., Smith, P. A., Wilkinson, R., Latner, A. L., and Miller, H. (1967): Endocrine activity in multiple sclerosis. Lancet 1, 64–68.CrossRefGoogle ScholarPubMed
Weitzman, E. D. (1975): Neuroendocrine pattern of secretion during the sleep-wake cycle of man. Prog. Brain Res. 42, 93–102.CrossRefGoogle ScholarPubMed
Weitzman, E. D., Fukushima, D., Nogeire, C., Roffwarg, H., Gallagher, T. F., and Hellman, L. (1971): Twenty-four-hour pattern of the episodic secretion of cortisol in normal subjects. J. clin. Endocrinol. Metab. 33, 14–22.CrossRefGoogle ScholarPubMed
Schumacher, G. A., Beebe, G., Kibler, R. F., Kurland, L. T., Kurtzke, J. F., Mcdowell, F., Nagler, B., Sibley, W. A., Tourtellotte, W. W., and Willmon, T. L. (1965): Problems of experimental trials of therapy in multiple sclerosis: Report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. N.Y. Acad. Sci. Ann. 122, 552–568.CrossRefGoogle Scholar
Teasdale, G. M., Smith, P. A., Wilkinson, R., Latner, A. L., and Miller, H. (1967): Endocrine activity in multiple sclerosis. Lancet 1, 64–68.CrossRefGoogle ScholarPubMed
Weitzman, E. D. (1975): Neuroendocrine pattern of secretion during the sleep-wake cycle of man. Prog. Brain Res. 42, 93–102.CrossRefGoogle ScholarPubMed
Weitzman, E. D., Fukushima, D., Nogeire, C., Roffwarg, H., Gallagher, T. F., and Hellman, L. (1971): Twenty-four-hour pattern of the episodic secretion of cortisol in normal subjects. J. clin. Endocrinol. Metab. 33, 14–22.CrossRefGoogle ScholarPubMed